GAD1 and multiple sclerosis: Such presumably nonpathogenic low GAD‐ab levels have also been detected in other autoimmune neurological disorders such as myasthenia gravis and multiple sclerosis and have been considered merely as nonspecific markers of an inflammatory condition [4].